Treasury Chief Rachel Reeves Aims for Focused Action on Living Costs in Upcoming Financial Plan
Treasury head Reeves has stated she is preparing "specific action to tackle cost of living issues" in the forthcoming Budget.
Speaking to media outlets, she noted that reducing price rises is a shared duty of both the administration and the central bank.
The UK's price growth is projected to be the most elevated among the Group of Seven developed nations this year and the following year.
Potential Energy Cost Interventions
It is understood the government could intervene to reduce energy bills, such as by slashing the current 5% rate of value-added tax charged on energy.
Another option is to reduce some of the government charges presently added to household expenses.
Fiscal Limitations and Expert Predictions
The government will receive the latest assessment from the independent fiscal watchdog, the OBR, on Monday, which will reveal how much space there is for these measures.
The expectation from most economists is that Reeves will have to introduce tax increases or expenditure reductions in order to fulfill her self-imposed borrowing rules.
Previously on Thursday, analysis showed there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of expectations.
"It is a joint job between the Bank of England and the government to further reduce some of the drivers of price increases," Reeves stated to the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.
Revenue Pledges and International Issues
While a great deal of the focus has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her commitment to manifesto promises not to increase rates on income tax, VAT or social security contributions.
She blamed an "unpredictable global environment" with increasing international and commercial tensions for the Budget tax moves, probably to be targeted on those "with the broadest shoulders."
Global Economic Tensions
Addressing worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security invariably are paramount."
Recent statement by Chinese authorities to tighten export controls on critical minerals and other resources that are crucial for high-technology production led US President the US President to suggest an extra 100% tariff on goods from China, raising the possibility of an full-scale trade war between the two global powers.
The US Treasury Secretary called China's move "commercial pressure" and "a international production power grab."
Questioned on considering the US offer to join its conflict with the Asian nation, Reeves said she was "deeply worried" by China's actions and called on the Chinese government "to avoid restrictions and limit trade."
She said the decision was "bad for the international commerce and causes additional obstacles."
"It is my opinion there are sectors where we must confront Chinese policies, but there are also valuable chances to sell into Chinese markets, including financial services and other sectors of the economic system. We've got to achieve that equilibrium correct."
The chancellor also affirmed she was working with other major economies "regarding our own essential resources approach, so that we are less reliant."
NHS Medicine Costs and Funding
The Chancellor also recognized that the price the NHS spends on drugs could go up as a result of current discussions with the Trump administration and its drugs companies, in exchange for reduced taxes and capital.
A number of the biggest global pharmaceutical manufacturers have said in recent statements that they are either halting or canceling projects in the UK, with several attributing the insufficient payments they are receiving.
Recently, the government science advisor said the price the NHS spends on medicines would must increase to halt companies and drug research funding leaving the UK.
Reeves told media: "We have seen because of the payment system, that medical research, new drugs have not been provided in the UK in the manner that they are in other European countries."
"We want to guarantee that people receiving treatment from the NHS are can receive the finest life-saving treatments in the globe. And so we are looking at all of that, and... looking to secure additional investment into the UK."